The Moving Average Convergence Divergence (MACD) for CANC turned positive on October 20, 2026. Looking at past instances where CANC's MACD turned positive, the stock continued to rise in 27 of 28 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CANC as a result. In 47 of 54 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
Following a +4.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where CANC advanced for three days, in 172 of 196 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
CANC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
CANC moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CANC crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CANC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for CANC entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
RCUS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 32 cases where RCUS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +7.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCUS advanced for three days, in 219 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RCUS as a result. In 73 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for RCUS turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 37 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for RCUS entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.088) is normal, around the industry mean (3.043). P/E Ratio (-4.706) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (25.063) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. RCUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCUS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
RCUS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 27 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 57 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 65 | |
P/E GROWTH RATING 1..100 | 15 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CANC | RCUS | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 79% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 87% | 2 days ago 80% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 80% |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 77% |
| Advances ODDS (%) | 5 days ago 88% | 5 days ago 78% |
| Declines ODDS (%) | 2 days ago 83% | 12 days ago 78% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 88% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 79% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GVI | 103.95 | -0.09 | -0.09% |
| iShares Intermediate Government/Credit Bond ETF (GVI) | |||
| IBHG | 21.74 | -0.02 | -0.11% |
| iShares iBonds 2027 Term High Yield and Income ETF (IBHG) | |||
| YSPY | 15.08 | -0.05 | -0.35% |
| GraniteShares YieldBOOST SPY ETF (YSPY) | |||
| PIM | 2.98 | -0.02 | -0.67% |
| Picard Medical Inc | |||
| PSIL | 20.64 | -0.29 | -1.39% |
| AdvisorShares Psychedelics ETF (PSIL) | |||
A.I.dvisor indicates that over the last year, CANC has been loosely correlated with KURA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CANC jumps, then KURA could also see price increases.
| Ticker / NAME | Correlation To CANC | 1D Price Change % | ||
|---|---|---|---|---|
| CANC | 100% | -0.50% | ||
| KURA - CANC | 65% Loosely correlated | -2.54% | ||
| IMNM - CANC | 64% Loosely correlated | -1.48% | ||
| IDYA - CANC | 58% Loosely correlated | -3.90% | ||
| IMCR - CANC | 56% Loosely correlated | -3.55% | ||
| ARVN - CANC | 55% Loosely correlated | -5.44% | ||
More | ||||
A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with VIR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then VIR could also see price increases.
| Ticker / NAME | Correlation To RCUS | 1D Price Change % | ||
|---|---|---|---|---|
| RCUS | 100% | -4.24% | ||
| VIR - RCUS | 49% Loosely correlated | +1.34% | ||
| XNCR - RCUS | 49% Loosely correlated | -2.55% | ||
| KURA - RCUS | 46% Loosely correlated | -2.54% | ||
| NRIX - RCUS | 44% Loosely correlated | -0.67% | ||
| BCAX - RCUS | 44% Loosely correlated | -3.07% | ||
More | ||||